Summary
Michele Cane is an Associate Director with 12 years of experience blending neuroscience expertise and commercial analytics to drive product launches and market strategy in rare disease and gene therapy. Holding a PhD in neuroscience, she has led global launch excellence, commercial analytics, and medical operations for high-profile therapies including Zolgensma and haemoglobinopathy programs. Michele excels at turning complex scientific and real-world data into actionable commercial insights, building digital solutions and cross‑functional capabilities across matrixed global and regional teams. A fast learner who thrives at the intersection of science and business, she has repeatedly led forecasting, competitive intelligence and sales excellence initiatives that enabled strategic decision-making during launches. Based in Zurich, she brings a scientist’s rigor to commercial strategy and a track record of translating research-born curiosity into measurable market impact.
13 years of coding experience
High School, High School at Collegio Papio
PhD, Neuroscience, PhD, Neuroscience at University of Geneva
Italian, English, French, German